Home / Fact sheets / Spain / Spain (Basque Country) / Cervical qualitative data

Country fact sheet: Spain (Basque Country)

CERVICAL CANCER SCREENING PROGRAMME

Reporting year for qualitative data: 2020
Source of qualitative data: Directly from Programme

Organization of screening

An individual/team/institution responsible to coordinate the programme: Yes
Dedicated budget for screening programme: Yes
Documented cancer screening policy: Yes
Nature of documentation of the policy: Notification
Year programme was initiated: 2018
Programme introduction was preceded by a pilot: Yes, pilot evaluated but no report published
Screening tests provided free of charge: Yes
Diagnostic tests provided free of charge: Yes
Treatment services provided free of charge: Yes

Information system and data collection

System that collects data: Individual & Aggregated
   • Identification of eligible population: Individual
   • Screening participation: Individual & Aggregated
   • Screening test results: Individual & Aggregated
   • Further assessment: Individual & Aggregated
   • Final pathology diagnosis: Individual & Aggregated
   • Cancer staging: Individual & Aggregated
   • Treatment: Individual & Aggregated
The information system exists at national or sub-national level: Individual: Sub-national
Aggregated: Sub-national
The information system collects data outside the programme (opportunistic screening/private sector): Yes
Cancer screening data is linked with population-based cancer registry (PBCR): Yes

Screening protocol

A screening protocol or guideline: Yes
Year of published/updated protocol: 2019
Target age (min-max) and screening interval [months] for each test: Cytology (25-34 years / [36 months])
HPV (35-65 years / [60 months])
Triaging test used: Other
Self-collection HPV recommended: No
"Screen and treat" included in the protocol: No
Treatment modality for "screen and treat": -

Invitations for screening and further assessment

Initiatives to create population awareness by the Health Ministry/Health Authority: Mass media campaign
Group education
One-on-one education
Dedicated website
Invitations to eligible population: Yes
Source of the eligible individuals identified: Population register
Electorall roll
Method of invitation: Letter
Screening kit included with the invitation: No
Screen positive individuals actively contacted for further assessment: Yes
Individuals with a precancer or cancer diagnosis actively contacted: Yes

Quality Assurance (QA) of screening activities

Documented standard operating procedure/policy for QA: Yes
An individual/team/institution responsible for QA: Yes
Accreditation of lab services: Yes
Accreditation of pathology services: Yes
Documented performance indicators: Yes
Reference standards for performance indicators: Yes
Evaluation reports published in the last five years: No

Sub-national data is available for:
   • Basque Country (2020)

Performance indicators

Reporting year for quantitative data: 2016
Source of quantitative data: Report (EU Report 2017)
Age range and regional limitation if applicable:
Invitation coverage (%):
Participation rate (%):
Examination coverage (%):
Completeness of data related to screening test results (%):
Completeness of data related to further assessment results (%):
Further assessment (Colposcopy referral) rate (%):
Further assessment participation rate (%):
Detection rate of CIN2+ (x 1000):
Detection rate of CIN3+ (x 1000):
Positive Predictive Value of abnormal screening test to detect CIN2+ (x 1000):
Positive Predictive Value of CIN3+ (x 1000):


Check also the following factsheets: Spain, Breast, Colorectal